Erica W van Tilburg
Overview
Explore the profile of Erica W van Tilburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavalli S, Houben A, Albers H, van Tilburg E, de Ru A, Aoki J, et al.
Chembiochem
. 2010 Oct;
11(16):2311-7.
PMID: 20941725
Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), is a secreted lysophospholipase D that hydrolyses lysophosphatidylcholine into the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types....
2.
Albers H, van Meeteren L, Egan D, van Tilburg E, Moolenaar W, Ovaa H
J Med Chem
. 2010 Jun;
53(13):4958-67.
PMID: 20536182
Autotaxin (ATX) is an extracellular enzyme that hydrolyzes lysophosphatidylcholine (LPC) to produce the lipid mediator lysophosphatidic acid (LPA). The ATX-LPA signaling axis has been implicated in diverse physiological and pathological...
3.
Albers H, Dong A, van Meeteren L, Egan D, Sunkara M, van Tilburg E, et al.
Proc Natl Acad Sci U S A
. 2010 Apr;
107(16):7257-62.
PMID: 20360563
Autotaxin (ATX) is a secreted nucleotide pyrophosphatase/phosphodiesterase that functions as a lysophospholipase D to produce the lipid mediator lysophosphatidic acid (LPA), a mitogen, chemoattractant, and survival factor for many cell...
4.
Yaqub M, Tolboom N, Boellaard R, van Berckel B, van Tilburg E, Luurtsema G, et al.
Neuroimage
. 2008 Jun;
42(1):76-86.
PMID: 18541442
The purpose of the present study was to evaluate the performance of various parametric reference tissue models for quantification of [11C]PIB studies. Several models with and without fixing the reference...
5.
Berkers C, van Leeuwen F, Groothuis T, Peperzak V, van Tilburg E, Borst J, et al.
Mol Pharm
. 2007 Aug;
4(5):739-48.
PMID: 17708652
With proteasome inhibitors in use in the clinic for the treatment of multiple myeloma and with clinical trials in progress investigating the treatment of a variety of hematologic and solid...
6.
Schaddelee M, Voorwinden H, van Tilburg E, Pateman T, IJzerman A, Danhof M, et al.
Eur J Pharm Sci
. 2003 May;
19(1):13-22.
PMID: 12729857
The objective of this investigation was to determine the functional role of adenosine receptor subtypes in the regulation of blood-brain barrier (BBB) permeability. The presence of the equilibrative es and...
7.
van Tilburg E, Gremmen M, von Frijtag Drabbe Kunzel J, de Groote M, Ijzerman A
Bioorg Med Chem
. 2003 Apr;
11(10):2183-92.
PMID: 12713828
Novel 2,8-disubstituted adenosine derivatives were synthesized in good overall yields starting from 2-iodoadenosine. Binding affinities were determined for rat adenosine A(1) and A(2A) receptors and human A(3) receptors. Some compounds...
8.
van Tilburg E, von Frijtag Drabbe Kunzel J, de Groote M, Ijzerman A
J Med Chem
. 2002 Jan;
45(2):420-9.
PMID: 11784146
Novel 2,5'-disubstituted adenosine derivatives were synthesized in good overall yields starting from commercially available guanosine. Binding affinities were determined for rat adenosine A(1) and A(2A) receptors and human A(3) receptors....